The Essential Oil of Artemisia argyi H.Lév. and Vaniot Attenuates NLRP3 Inflammasome Activation in THP-1 Cells

Pengxiao Chen,Qi Bai,Yanting Wu,Qiongzhen Zeng,Xiaowei Song,Yuying Guo,Pengjun Zhou,Yao Wang,Xiaofeng Liao,Qiaoli Wang,Zhe Ren,Yifei Wang
DOI: https://doi.org/10.3389/fphar.2021.712907
IF: 5.6
2021-09-16
Frontiers in Pharmacology
Abstract:Artemisia argyi H. Lév. and Vaniot is a traditional medical herb that has been used for a long time in China and other Asian counties. Essential oil is the main active fraction of Artemisia argyi H. Lév. and Vaniot, and its anti-inflammatory potential has been observed in vitro and in vivo . Here, we found that the essential oil of Artemisia argyi H. Lév. and Vaniot (EOAA) inhibited monosodium urate (MSU)- and nigericin-induced NLRP3 inflammasome activation. EOAA suppressed caspase-1 and IL-1β processing and pyroptosis. NF-κB p65 phosphorylation and translocation were also inhibited. In addition, EOAA suppressed nigericin-induced NLRP3 inflammasome activation without blocking ASC oligomerization, suggesting that it may inhibit NLRP3 inflammasome activation by preventing caspase-1 processing. Our study thus indicates that EOAA inhibits NLRP3 inflammasome activation and has therapeutic potential against NLRP3-driven diseases.
pharmacology & pharmacy
What problem does this paper attempt to address?